Document Detail


Clinical outcomes of patients treated with Nobori biolimus-eluting stent: Meta-analysis of randomized trials.
MedLine Citation:
PMID:  25012497     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUNDS: The Nobori is a new-generation, biodegradable-polymer coated, biolimus-eluting stent (BES) that has recently been investigated in several randomized trials with inconsistent results. The aim of this study was to assess the efficacy and safety of Nobori BES versus other drug-eluting stents (DES) in patients treated with percutaneous coronary intervention (PCI).
METHODS: We undertook a meta-analysis of randomized trials investigating Nobori BES versus other DES. Primary efficacy and safety outcomes were target lesion revascularization (TLR) and definite/probable stent thrombosis (ST), respectively. Secondary outcomes were the composite of cardiac death/myocardial infarction (MI)/target vessel revascularization (TVR), MI and death.
RESULTS: A total of 9114 PCI-patients randomly received Nobori BES (n=5080) or other DES (n=4034). This latter group comprised patients receiving everolimus- (n=2533), sirolimus- (n=1376) or paclitaxel-eluting stents (n=125). Median follow-up was 11months [interquartile range 9-12]. The Nobori BES versus other DES showed comparable risk of TLR (odds ratio [95% confidence interval]=0.91 [0.57-1.46], p=0.71). There was significant heterogeneity across trials due to significant lower TLR risk with Nobori BES versus paclitaxel-eluting stent (0.32 [0.10-0.98], p=0.046; p for interaction=0.009). Nobori BES versus other DES showed comparable risk of definite/probable ST (1.40 [0.66-2.97], p=0.39), cardiac death/MI/TVR (1.05 [0.88-1.25], p=0.59), MI (1.13 [0.87-1.48], p=0.37) and death (1.09 [0.81-1.48], p=0.56).
CONCLUSIONS: Nobori BES has comparable efficacy with other limus-eluting stents at 1-year follow-up. There is no difference in terms of safety profile between these stent platforms.
Authors:
Salvatore Cassese; Massimiliano Fusaro; Robert A Byrne; Tomohisa Tada; Petra Hoppmann; Michael Joner; Karl-Ludwig Laugwitz; Heribert Schunkert; Adnan Kastrati
Related Documents :
21455107 - Circadian variation of acute st segment elevation myocardial infarction by anatomic loc...
10647797 - Association between minor elevations of creatine kinase-mb level and mortality in patie...
21530167 - Coronary artery plaque burden does not affect left ventricular diastolic function in as...
21498307 - Delayed-enhancement mri of apical hypertrophic cardiomyopathy: assessment of the intram...
17908527 - Sexual activity and chronic heart failure.
2521417 - Regression of left ventricular mass is accompanied by improvement in rapid left ventric...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-28
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-7-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transient variations of transthoracic impedance as a predictor of heart failure and death in patient...
Next Document:  Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovas...